POM vs VIPS
Pomdoctor Ltd. and Vipshop Holdings Ltd., side by side — 3 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | POM | VIPS |
|---|---|---|
| Revenue | CNY 399.9M | CNY 105.9B |
| Net income | CNY -130.9M | CNY 7.2B |
| Gross margin | · | 23.1% |
| Net margin | · | 7.0% |
| Return on equity | · | 17.9% |
| Diluted EPS | −CNY 21.96 | CNY 70.74 |
| Dividend / share | · | · |
| Payout ratio | · | 24.8% |
| Free cash flow | CNY -149.5M | CNY 5.5B |
| Equity | CNY -454.0M | CNY 41.0B |
| Net debt / equity | · | −0.42× |
| Current ratio | 0.48× | 1.28× |
| Revenue CAGR 5y | · | 0.8% |
| Profit CAGR 5y | · | · |
VIPS bills 264.9× the revenue of POM, and POM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
Revenue by year
3 years side by side
| Fiscal year | POM | VIPS |
|---|---|---|
| FY2025 | CNY 399.9M | CNY 105.9B |
| FY2024 | CNY 342.6M | CNY 108.4B |
| FY2023 | CNY 304.9M | CNY 112.9B |
Net income by year
Bottom line
| Fiscal year | POM | VIPS |
|---|---|---|
| FY2025 | CNY -130.9M | CNY 7.2B |
| FY2024 | CNY -37.4M | CNY 7.7B |
| FY2023 | CNY -36.9M | CNY 8.1B |
More in this industry